Keratoconus (KC) is a common bilateral, non-inflammatory, degenerative axial ectatic condition of the cornea in which the cornea assumes an irregular conical shape. The aim of this study was to assess how effective corneal collagen cross-linking (CXL) is as a treatment for KC. A total of 63 participants were included, comprising 43 males (68.25%) and 20 females (31.74%). After the procedure, participants were followed up at 3-day, 10-day, 4-month, and 6 months from date of surgery. At the 4-month follow-up, there was a significant improvement in Best Corrected Visual Acuity (BCVA), with the mean for the right eye decreasing to 0.48 0.39 and for the left eye to 0.43 0,39. The results from the study's comprehensive analysis and results strongly affirm the effectiveness of CXL as an effective therapeutic approach for managing KC in children. The observed potential modifications in corneal biomechanics and shape dynamics that occur post-procedure are crucial for assessing the long-term effects of the procedure on corneal health and refractive outcomes in KC patients. The evidence gathered not only showcases the notable improvements in visual acuity resulting from the procedure but also provides valuable insights into how the cornea responds and adapts to the treatment.